Debt-to-equity of ORTHOPEDIATRICS CORP from 30 Jun 2018 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
ORTHOPEDIATRICS CORP quarterly Debt-to-equity in % history and change rate from 30 Jun 2018 to 30 Sep 2025.
  • ORTHOPEDIATRICS CORP Debt-to-equity for the quarter ending 30 Sep 2025 was 38%, a 85% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

ORTHOPEDIATRICS CORP Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 38% +17% +85% 30 Sep 2025
Q2 2025 36% +19% +116% 30 Jun 2025
Q1 2025 29% +13% +81% 31 Mar 2025
Q4 2024 25% +9.6% +64% 31 Dec 2024
Q3 2024 21% +6.3% +44% 30 Sep 2024
Q2 2024 16% +3% +23% 30 Jun 2024
Q1 2024 16% -2.5% -14% 31 Mar 2024
Q4 2023 15% -8.6% -36% 31 Dec 2023
Q3 2023 14% -16% -52% 30 Sep 2023
Q2 2023 13% -26% -66% 30 Jun 2023
Q1 2023 19% -19% -51% 31 Mar 2023
Q4 2022 24% -14% -38% 31 Dec 2022
Q3 2022 30% -8.4% -22% 30 Sep 2022
Q2 2022 40% +3.4% +9.4% 30 Jun 2022
Q1 2022 38% +2.4% +6.9% 31 Mar 2022
Q4 2021 38% +5.9% +18% 31 Dec 2021
Q3 2021 38% +8.4% +28% 30 Sep 2021
Q2 2021 36% -1.3% -3.4% 30 Jun 2021
Q1 2021 35% -9.8% -22% 31 Mar 2021
Q4 2020 32% -19% -37% 31 Dec 2020
Q3 2020 30% -27% -48% 30 Sep 2020
Q2 2020 37% -18% -33% 30 Jun 2020
Q1 2020 45% -9.9% -18% 31 Mar 2020
Q4 2019 51% -15% -23% 31 Dec 2019
Q3 2019 57% -24% -30% 30 Sep 2019
Q2 2019 56% -178% -76% 30 Jun 2019
Q1 2019 55% 31 Mar 2019
Q4 2018 66% 31 Dec 2018
Q3 2018 82% 30 Sep 2018
Q2 2018 234% 30 Jun 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.